Daksh Thaper

1.5k total citations
21 papers, 779 citations indexed

About

Daksh Thaper is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daksh Thaper has authored 21 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Daksh Thaper's work include Prostate Cancer Treatment and Research (13 papers), Cancer, Lipids, and Metabolism (3 papers) and Protein Degradation and Inhibitors (3 papers). Daksh Thaper is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Cancer, Lipids, and Metabolism (3 papers) and Protein Degradation and Inhibitors (3 papers). Daksh Thaper collaborates with scholars based in Canada, United States and United Kingdom. Daksh Thaper's co-authors include Amina Zoubeidi, Jennifer L. Bishop, Sepideh Vahid, Ladan Fazli, Martin Gleave, Alastair Davies, Ka Mun Nip, Soojin Kim, Kirsi Ketola and Eliana Beraldi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Daksh Thaper

21 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daksh Thaper Canada 12 471 465 241 207 88 21 779
Valerie M. Jansen United States 14 479 1.0× 304 0.7× 583 2.4× 273 1.3× 53 0.6× 38 896
Henri Sara Finland 9 191 0.4× 664 1.4× 238 1.0× 280 1.4× 54 0.6× 11 883
Anousheh Zardan Canada 8 262 0.6× 488 1.0× 247 1.0× 171 0.8× 61 0.7× 15 749
Marta Palafox Spain 9 482 1.0× 393 0.8× 604 2.5× 245 1.2× 48 0.5× 12 914
Meaghan A. Delaney United States 6 145 0.3× 449 1.0× 255 1.1× 140 0.7× 41 0.5× 7 714
Sigrun Erkens‐Schulze Netherlands 14 315 0.7× 231 0.5× 238 1.0× 178 0.9× 73 0.8× 20 620
Ali Sak Germany 17 164 0.3× 656 1.4× 313 1.3× 238 1.1× 38 0.4× 33 908
Tamara Jamaspishvili Canada 11 453 1.0× 430 0.9× 187 0.8× 279 1.3× 30 0.3× 20 795
Jonathan T. Lei United States 11 207 0.4× 263 0.6× 175 0.7× 130 0.6× 89 1.0× 30 585
Kevin McMahon Ireland 11 318 0.7× 324 0.7× 188 0.8× 136 0.7× 40 0.5× 15 731

Countries citing papers authored by Daksh Thaper

Since Specialization
Citations

This map shows the geographic impact of Daksh Thaper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daksh Thaper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daksh Thaper more than expected).

Fields of papers citing papers by Daksh Thaper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daksh Thaper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daksh Thaper. The network helps show where Daksh Thaper may publish in the future.

Co-authorship network of co-authors of Daksh Thaper

This figure shows the co-authorship network connecting the top 25 collaborators of Daksh Thaper. A scholar is included among the top collaborators of Daksh Thaper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daksh Thaper. Daksh Thaper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tam, Kevin J., Liangliang Liu, Michael Hsing, et al.. (2024). Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer. Scientific Reports. 14(1). 7082–7082. 2 indexed citations
2.
Ganguli, Dwaipayan, Maxim Kobelev, Olena Sivak, et al.. (2022). ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer. Nature Communications. 13(1). 2282–2282. 68 indexed citations
3.
Ritch, Elie, et al.. (2020). Genome-wide CRISPR screen reveals SLFN11 as a potent mediator of cisplatin sensitivity in muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(12). 905–905. 3 indexed citations
4.
Thaper, Daksh, Sepideh Vahid, & Amina Zoubeidi. (2019). Neural Transcription Factors in Disease Progression. Advances in experimental medicine and biology. 1210. 437–462. 3 indexed citations
5.
Kim, Soojin, Daksh Thaper, Samir Bidnur, et al.. (2019). PEG10 is associated with treatment-induced neuroendocrine prostate cancer. Journal of Molecular Endocrinology. 63(1). 39–49. 28 indexed citations
6.
Thaper, Daksh, Sahil Kumar, Soojin Kim, et al.. (2019). First-in-field small molecule inhibitors targeting BRN2 as a therapeutic strategy for small cell prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 260–260. 3 indexed citations
7.
Thaper, Daksh, Sahil Kumar, Soojin Kim, et al.. (2019). Abstract 1295: First-in-field small molecule inhibitors targeting BRN2 as a therapeutic strategy for small cell prostate cancer. 1295–1295. 1 indexed citations
8.
Thaper, Daksh, Sepideh Vahid, Ramandeep Kaur, et al.. (2018). Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer. Scientific Reports. 8(1). 17307–17307. 25 indexed citations
9.
Thaper, Daksh, Sepideh Vahid, Ka Mun Nip, et al.. (2017). Targeting Lyn regulates Snail family shuttling and inhibits metastasis. Oncogene. 36(28). 3964–3975. 30 indexed citations
10.
Bishop, Jennifer L., Daksh Thaper, Sepideh Vahid, et al.. (2016). The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer. Cancer Discovery. 7(1). 54–71. 263 indexed citations
11.
Vahid, Sepideh, et al.. (2016). Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer. Scientific Reports. 6(1). 31842–31842. 42 indexed citations
12.
Vahid, Sepideh, Daksh Thaper, & Amina Zoubeidi. (2016). Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer. Recent Patents on Anti-Cancer Drug Discovery. 12(1). 35–47. 19 indexed citations
13.
Vahid, Sepideh, Daksh Thaper, & Amina Zoubeidi. (2015). Abstract 4956: Hsp27 negatively affects Hippo tumor suppressor pathway to regulate cell survival in cancer. Cancer Research. 75(15_Supplement). 4956–4956. 1 indexed citations
14.
Thaper, Daksh, Sepideh Vahid, Jennifer L. Bishop, Martin Johansson, & Amina Zoubeidi. (2015). Abstract 728: New derivative of galiellalactone inhibits the STAT3 activity and suppresses ENZ-resistant Prostate Cancer in vitro. Cancer Research. 75(15_Supplement). 728–728. 1 indexed citations
15.
Bishop, Jennifer L., et al.. (2015). Reduction in PD-L1 expression by STAT3 inhibition with GPA500 in enzalutamide-resistant prosate cancer.. Journal of Clinical Oncology. 33(15_suppl). e16075–e16075. 1 indexed citations
16.
Zardan, Anousheh, Ka Mun Nip, Daksh Thaper, et al.. (2014). Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer. Oncogenesis. 3(8). e115–e115. 25 indexed citations
17.
Bishop, Jennifer L., Daksh Thaper, & Amina Zoubeidi. (2014). The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer. Cancers. 6(2). 829–859. 120 indexed citations
18.
Takeuchi, Ario, Masaki Shiota, Eliana Beraldi, et al.. (2014). Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth. Molecular and Cellular Endocrinology. 384(1-2). 117–125. 15 indexed citations
19.
Thomas, Christian, François Lamoureux, Claire Crafter, et al.. (2013). Synergistic Targeting of PI3K/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer Progression In Vivo. Molecular Cancer Therapeutics. 12(11). 2342–2355. 115 indexed citations
20.
Thomas, Christian, François Lamoureux, Claire Crafter, et al.. (2013). 318 SYNERGISTIC TARGETING OF PI3K/AKT-PATHWAY AND ANDROGEN-RECEPTOR AXIS SIGNIFICANTLY DELAYS CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION IN VIVO. The Journal of Urology. 189(4S). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie M. Jansen Breakdown of academic impact, for papers by Henri Sara Breakdown of academic impact, for papers by Anousheh Zardan Breakdown of academic impact, for papers by Marta Palafox Breakdown of academic impact, for papers by Meaghan A. Delaney Breakdown of academic impact, for papers by Sigrun Erkens‐Schulze Breakdown of academic impact, for papers by Ali Sak Breakdown of academic impact, for papers by Tamara Jamaspishvili Breakdown of academic impact, for papers by Jonathan T. Lei Breakdown of academic impact, for papers by Kevin McMahon
Rankless by CCL
2026